ABOUT THE DYNAMIC DEVELOPMENT OF THE HEALTH AND PHARMACEUTICAL SECTOR IN AZERBAIJAN

2021

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.36962/0601202181
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Introduction: In the Republic of Azerbaijan in the period 2009-2019 years for the implementation of large-scale measures for the dynamic development of healthcare, decrees were signed on the approval of the State Program for the implementation of the development of the National Strategy in this, mainly, this is strengthening the material and technical base of medical institutions, the use of modern methods of examination and treatment, improving the quality of medical and pharmaceutical services to the population, state regulation of prices for essential medicines, training and improvement of personnel, introduction of compulsory health insurance [1,2,3]. Goal: The purpose of this work was to study the new economic foundations of financing the healthcare system in Azerbaijan, analyze the reforms in healthcare and the pharmaceutical sector, and apply them in practice. To achieve this goal, a number of local regulatory laws, as well as the activities of medical and pharmaceutical services to the population, were studied. Discussion: During this period, our country has taken extensive measures to solve problems in the field of healthcare and the pharmaceutical sector. The regulatory legal acts governing pharmaceutical activities have been approved. In particular, state regulation of prices in the sphere of circulation of medicines has been introduced to prevent unjustified increases, as well as the application of measures of liability provided for by the legislation of the Republic of Azerbaijan for violation of the pricing procedure for medicines included in the list of essential medicines. In accordance with international standards, the quality control of medicines has been strengthened, the rules for issuing medicines have been improved, new prescription forms have been introduced, and admission to doctors is monitored [4,5]. Keywords: healthcare, pharmaceutical sector, reform analysis